P

Vaxcyte

PCVX

78.600
USD
-0.35
(-0.44%)
Market Closed
Volume
21,123
EPS
0
Div Yield
0
P/E
-24
Market Cap
13,947,856,721
News

Title: Vaxcyte

Sector: Healthcare
Industry: Biotechnology
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.